InvestorsHub Logo
Followers 1
Posts 307
Boards Moderated 0
Alias Born 07/24/2015

Re: pax33 post# 258946

Tuesday, 03/31/2020 5:36:16 PM

Tuesday, March 31, 2020 5:36:16 PM

Post# of 429479
Pax, I think markman is very wrong in their conclusion that generics wouldn’t at-risk launch. Generics slit each other’s throats to be first in the market because that gives them a huge head start on market share, and market share is almost everything since they don’t compete on price or quality in a meaningful way. Unless there’s an injunction, they will be chomping at the bit to launch. They are effectively competing for cashflows in perpetuity by securing market share today.

Lots of bad news, but better to be honest and face the painful reality.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News